SEC Form 4 · accession 0001193125-26-294694
Q32 Bio Inc. · QTTB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isaac Manke
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001661998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | M | 53,521 | $2.80 | A | 53,521 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.80 | Jun 30, 2026 | M | 53,521 | D | — | Oct 22, 2035 | Common Stock | 53,521 | 0 | D |
Explanation of responses
- F1The shares underlying this option are fully vested and exercisable.